FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3193304641> ?p ?o ?g. }

• W3193304641 abstract "Abstract Background Increasing the availability of naloxone among people who use opioids, and friends and family of past and present people who use opioids is a vitally important mission to reduce the occurrence of opioid-related overdose deaths. The purpose of this study was to determine the availability of naloxone in independent community pharmacies in Georgia. Secondary objectives include determining pharmacists’ knowledge regarding the standing order and ability to counsel regarding naloxone. Methods A cross-sectional study using a secret shopper approach with phone contact was conducted over a period of 10 months. The study was population based and was conducted at all independent pharmacies in the state of Georgia. All independent community pharmacies in the state of Georgia were contacted and asked the naloxone questions with a 96% response rate ( n = 520). Results Five hundred fifty-eight independent community pharmacies were called, with a 96% response rate (n = 520 pharmacies). Two hundred-twenty pharmacies reported having naloxone in stock. Of the 335 pharmacists asked, 174 (51.9%) incorrectly said that a prescription was required. The mean (SD) cash price was $148.02 (27.40), with a range of $0 to $300. Of 237 pharmacists asked who had naloxone in stock or who stated they could get naloxone in stock, 212 stated that they could demonstrate how to use it, 8 stated they could not, and 17 said that they possibly could or were unsure how to use it. Conclusions This study provided insight into the limited availability of naloxone at independent community pharmacies in Georgia after the standing order was issued. The majority of pharmacists at independent pharmacies in Georgia were not using the publicly available state naloxone standing order. Additionally, the low availability of naloxone and its high cost for uninsured individuals are significant structural barriers for reducing opioid-related mortality." @default.
• W3193304641 created "2021-08-30" @default.
• W3193304641 creator A5011989799 @default.
• W3193304641 creator A5021254368 @default.
• W3193304641 creator A5023187210 @default.
• W3193304641 creator A5051286778 @default.
• W3193304641 creator A5064823094 @default.
• W3193304641 creator A5069260106 @default.
• W3193304641 date "2021-08-21" @default.
• W3193304641 modified "2023-10-18" @default.
• W3193304641 title "Naloxone availability in independent community pharmacies in Georgia, 2019" @default.
• W3193304641 cites W2005677494 @default.
• W3193304641 cites W2560212357 @default.
• W3193304641 cites W2585540506 @default.
• W3193304641 cites W2587995871 @default.
• W3193304641 cites W2766833490 @default.
• W3193304641 cites W2789777039 @default.
• W3193304641 cites W2801514601 @default.
• W3193304641 cites W2900690417 @default.
• W3193304641 cites W2901836732 @default.
• W3193304641 cites W2906950346 @default.
• W3193304641 cites W2918077387 @default.
• W3193304641 cites W2942776977 @default.
• W3193304641 cites W2944689007 @default.
• W3193304641 cites W2948673540 @default.
• W3193304641 cites W2966409306 @default.
• W3193304641 cites W2974005807 @default.
• W3193304641 cites W2977451683 @default.
• W3193304641 cites W2978173603 @default.
• W3193304641 cites W2980464977 @default.
• W3193304641 cites W2989661562 @default.
• W3193304641 cites W2990967525 @default.
• W3193304641 cites W2991208813 @default.
• W3193304641 cites W2999287971 @default.
• W3193304641 cites W3003198501 @default.
• W3193304641 cites W3005559651 @default.
• W3193304641 cites W3006592616 @default.
• W3193304641 cites W3009024940 @default.
• W3193304641 cites W3013120613 @default.
• W3193304641 cites W3013233608 @default.
• W3193304641 cites W3013906570 @default.
• W3193304641 cites W3090571660 @default.
• W3193304641 cites W3094872558 @default.
• W3193304641 cites W3096025577 @default.
• W3193304641 doi "https://doi.org/10.1186/s13011-021-00402-w" @default.
• W3193304641 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8379837" @default.
• W3193304641 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34419089" @default.
• W3193304641 hasPublicationYear "2021" @default.
• W3193304641 type Work @default.
• W3193304641 sameAs 3193304641 @default.
• W3193304641 citedByCount "8" @default.
• W3193304641 countsByYear W31933046412022 @default.
• W3193304641 countsByYear W31933046412023 @default.
• W3193304641 crossrefType "journal-article" @default.
• W3193304641 hasAuthorship W3193304641A5011989799 @default.
• W3193304641 hasAuthorship W3193304641A5021254368 @default.
• W3193304641 hasAuthorship W3193304641A5023187210 @default.
• W3193304641 hasAuthorship W3193304641A5051286778 @default.
• W3193304641 hasAuthorship W3193304641A5064823094 @default.
• W3193304641 hasAuthorship W3193304641A5069260106 @default.
• W3193304641 hasBestOaLocation W31933046411 @default.
• W3193304641 hasConcept C104863432 @default.
• W3193304641 hasConcept C126322002 @default.
• W3193304641 hasConcept C138816342 @default.
• W3193304641 hasConcept C138885662 @default.
• W3193304641 hasConcept C155164915 @default.
• W3193304641 hasConcept C159110408 @default.
• W3193304641 hasConcept C170493617 @default.
• W3193304641 hasConcept C194828623 @default.
• W3193304641 hasConcept C2426938 @default.
• W3193304641 hasConcept C2778707766 @default.
• W3193304641 hasConcept C2778750930 @default.
• W3193304641 hasConcept C2779148768 @default.
• W3193304641 hasConcept C2781063702 @default.
• W3193304641 hasConcept C2908647359 @default.
• W3193304641 hasConcept C41895202 @default.
• W3193304641 hasConcept C512399662 @default.
• W3193304641 hasConcept C545542383 @default.
• W3193304641 hasConcept C71924100 @default.
• W3193304641 hasConcept C99454951 @default.
• W3193304641 hasConceptScore W3193304641C104863432 @default.
• W3193304641 hasConceptScore W3193304641C126322002 @default.
• W3193304641 hasConceptScore W3193304641C138816342 @default.
• W3193304641 hasConceptScore W3193304641C138885662 @default.
• W3193304641 hasConceptScore W3193304641C155164915 @default.
• W3193304641 hasConceptScore W3193304641C159110408 @default.
• W3193304641 hasConceptScore W3193304641C170493617 @default.
• W3193304641 hasConceptScore W3193304641C194828623 @default.
• W3193304641 hasConceptScore W3193304641C2426938 @default.
• W3193304641 hasConceptScore W3193304641C2778707766 @default.
• W3193304641 hasConceptScore W3193304641C2778750930 @default.
• W3193304641 hasConceptScore W3193304641C2779148768 @default.
• W3193304641 hasConceptScore W3193304641C2781063702 @default.
• W3193304641 hasConceptScore W3193304641C2908647359 @default.
• W3193304641 hasConceptScore W3193304641C41895202 @default.
• W3193304641 hasConceptScore W3193304641C512399662 @default.
• W3193304641 hasConceptScore W3193304641C545542383 @default.
• W3193304641 hasConceptScore W3193304641C71924100 @default.
• W3193304641 hasConceptScore W3193304641C99454951 @default.
• W3193304641 hasIssue "1" @default.

• next